Results 51 to 60 of about 22,497,798 (252)

Lipoproteína(A) e massa corporal de ratos submetidos à hipercolesterolemia e treinamentos físicos de força e aeróbico

open access: yes, 2008
Introducao: O objetivo do estudo foi verificar os efeitos provocados pelos exercicios de forca e aerobico sobre as concentracoes plasmaticas lipoproteicas da lipoproteina(a) [Lp(a)] e massa corporal, em ratos submetidos a uma dieta hipercolesterolemica ...
Rosemeire Dantas de Almeida   +3 more
semanticscholar   +1 more source

Učinak diklorvosa na aktivnost butirilkolinesteraze i metabolizam lipida u štakora [PDF]

open access: yes, 2002
This paper describes the effects of dichlorvos (DDVP) on butyrylcholinesterase (BuChE) activity with possible consequences for lipid and lipoprotein metabolism in rats. The rats of both sexes were given a single and multiple doses of DDVP (8.0 mg/kg body
Ana Lucić   +6 more
core  

Povećani lipoprotein(a) – neovisni čimbenik kardiovaskularnog rizika – preporuke za određivanje i liječenje

open access: yesLiječnički vjesnik
Smjernice međunarodnih stručnih društava ukazuju da je povišena koncentracija lipoproteina(a) [Lp(a)] u krvi dugoročni neovisni čimbenik rizika za razvitak aterosklerotske kardiovaskularne bolesti (ASKVB), kao i za kalcifikacijsku stenozu aortnih ...
Željko Reiner   +10 more
doaj   +1 more source

Extreme lipoprotein(a) in clinical practice: A cross sectional study

open access: yesInternational Journal of Cardiology. Cardiovascular Risk and Prevention, 2023
Introduction: Measurement of lipoprotein(a) [Lp(a)] is recommended once in a lifetime to identify individuals at high risk of atherosclerotic cardiovascular disease (ASCVD).
Barak Zafrir, Amir Aker, Walid Saliba
doaj  

Lipoprotein(a) Testing Trends in a Large Academic Health System in the United States

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Despite its high prevalence and clinical significance, clinical measurement of lipoprotein(a) is rare but has not been systematically quantified.
Harpreet S. Bhatia   +4 more
doaj   +1 more source

Vino i ljudsko zdravlje [PDF]

open access: yes, 2018
History of wine consumption begins in prehistoric periods; a vast majority of early nations was giving divine status to one of the most popular alcoholic drinks, simply made by fermentation of Vitis vinifera grapes. Nowadays, a unique consensus on the
Bojić, Mirza   +3 more
core   +2 more sources

Avaliação dos níveis de lipídeos, lipoproteínas, apoproteínas e o papel da lipoproteína(a) no desenvolvimento de aterosclerose e alterações fibrinolíticas nos pacientes portadores de hanseníase virchoviana

open access: yesHansenologia Internationalis, 1997
Muitos pacientes portadores de hanseníase virchoviana, após longo tempo de evolução, apresentam alterações dérmicas muito semelhantes aos xantomas e seus exames histológicos mostram numerosos macrófagos carregados de material lipídico.
Dirceu Dalpino   +2 more
semanticscholar   +1 more source

Lipid Disorders in Children with Insulin-Dependent Diabetes Mellitus [PDF]

open access: yes, 1998
Os distúrbios dos lípidos e das lipoproteínas plasmáticas, frequentes em doentes diabéticos insulinodependentes, contribuem significativamente para o risco cardiovascular elevado que estes indivíduos apresentam.
Bogalho, P
core  

Non-alcoholic fatty liver disease in obese persons with diabetes [PDF]

open access: yes, 2007
Background. Obesity, diabetes and different lipid metabolic disorders are the most frequent risk factors for nonalcoholic fatty liver disease, presented with a high variability in clinical and histological findings. Case report. We presented a case of 37-
Dugalić Predrag   +5 more
core   +1 more source

Lipoproteína (a) em pacientes portadores de doença arterial obstrutiva periférica e/ou diabetes mellitus tipo 2

open access: yes, 2008
BACKGROUND: Peripheral arterial obstructive disease (PAOD) constitutes an excellent marker for systemic atherosclerosis and type 2 diabetes mellitus (DM2) is among the greatest risk factors for this disease. It is believed that lipoprotein (a) [Lp(a)] is
A. P. Mota   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy